SAB Biotherapeutics, Inc.
2 private offerings reported to the SEC on Form D since 2016, $182.5M sold in all. Biotech, Florida.
- Form D offerings: 2
- Reported sold: $182.5M
- Newest: Aug 5, 2025
- FDA records: Company page
Newest first; an amended notice updates the amount sold. Each filing opens on EDGAR.
| Aug 5, 2025 | โ | $175.0M | $175.0M | SAB Biotherapeutics, Inc.Biotech ยท Florida | Not amended | 0000950123-25-007031 |
| Oct 16, 2023 | โ | $7.5M | $7.5M | SAB Biotherapeutics, Inc.Biotech ยท South Dakota | Not amended | 0001209191-23-052843 |
- Ticker
- SABS
- Business address
- Miami Beach, FL
- Incorporated in
- Delaware
- SEC industry
- Biological Products, (No Diagnostic Substances)
- Former names
- Big Cypress Acquisition Corp.
- All SEC filings
- CIK 1833214 on EDGAR
- FDA records
- Approvals, clearances, recalls and letters
A Form D reports the amount offered and sold so far in a private offering, not who invested or at what valuation. Shares issued in a merger are left out. The profile is read from EDGAR daily. SEC Form D data sets and EDGAR